SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
ATXI

Avenue Therapeutics, Inc. (OTC:ATXI)

US · Delayed Price · Currency is USD
Healthcare · Biotechnology
$0.30+$0.00 (+0.00%)
 
Market cap
$988K
Insider Score
Health Score
Analyst consensus
Listed since
Jun 27, 2017
Market Cap$988.49K-60.9%
Revenue (ttm)$0-100.0%
Net Income-$2.79M+25.6%
EPS-$0.84-122.0%
Shares Out3.29M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume457
Open$0.30
Previous Close$0.30
Day's Range$0.30 - $0.30
52-Week Range$0.15 - $0.96
Betan/a
AnalystsBuy
Price Target$12.00(+3900.00%)
Earnings DateMar 23, 2027
No price history available.

About ATXI

Avenue Therapeutics, Inc. functions as a specialized pharmaceutical enterprise, primarily dedicated to innovating and bringing to market medical therapies tailored for critical and intensive care environments within hospitals. Their leading product candidate is intravenous Tramadol, a synthetic opioid with a dual mechanism of action, currently undergoing Phase III clinical trials for the management of severe pain experienced by patients after surgery. Established in 2015, the company's operations are based in New York, New York.

Address
1111 Kane Concourse, Bay Harbor Islands, FL, 33154, US
Market Cap
1 million
Employees
1
Industrial Classification
Biotechnology
Financial Health Score
Fair
From ATXI’s reported statements · Q3 2026 (trailing 12 months) · 4 of 5 pillars

Next catalysts

1 Day
+0.00%
5 Days
+7.14%
1 Month
-25.78%
6 Months
+24.54%
1 Year
-60.88%

$ATXI stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in ATXI holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by ATXI's directors and management

Net Shares Purchased by Insiders−1−102025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

ATXI Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New ATXI patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to ATXI from public contracts

Source: USAspending.gov

Bull Case vs Bear Case

AI-generated from ATXI’s recent data — informational, not investment advice

Generating analysis…

Recent Insider Activity

Buys
0
Sells
0
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.